OTC · CIK 0001089815
EHSI Elite Health Systems Inc.
Insider trading from SEC Form 4. Last filing 33 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
5
with a Form 4 at this company
Signals
Open-market buys and sells at Elite Health Systems Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Prasad Anjaneya jeereddi CEO buy | $2,250 3,000 shares | +0% | - | |
| 20Weak | Prasad Anjaneya jeereddi CEO buy | $2,500 3,000 shares | +0% | - |
Transactions
The last 15 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Prasad Anjaneya jeereddi CEO | AGrant or award Common stock warantsderivative | +68,421 | $0.00 | $0 | 178,947 | 33 d ago |
| Aug 6, 2025 | William St Lawrence director | AGrant or award Common Stock | +40,000 | $0.95 | $38k | 165,000 | Aug 8, 2025 |
| Aug 6, 2025 | William F. Leimkuhler director | AGrant or award Common Stock | +40,000 | $0.95 | $38k | 265,000 | Aug 8, 2025 |
| Aug 6, 2025 | Prasad Anjaneya jeereddi CEO | AGrant or award Common Stock | +375,000 | $0.95 | $356k | 1,903,983 | Aug 8, 2025 |
| Aug 6, 2025 | Kenneth A Minor Chief Financial Officer | AGrant or award 2025 Equity Incentive Planderivative | +75,000 | - | - | 75,000 | Aug 8, 2025 |
| Aug 6, 2025 | Alan Gold director | AGrant or award 2025 Equity Incentive Planderivative | +25,000 | - | - | 25,000 | Aug 8, 2025 |
| Aug 6, 2025 | William St Lawrence director | AGrant or award 2025 Equity Incentive Planderivative | +25,000 | - | - | 25,000 | Aug 8, 2025 |
| Aug 6, 2025 | William F. Leimkuhler director | AGrant or award 2025 Equity Incentive Planderivative | +25,000 | - | - | 25,000 | Aug 8, 2025 |
| Aug 6, 2025 | Prasad Anjaneya jeereddi CEO | AGrant or award 2025 Equity Incentive Planderivative | +125,000 | - | - | 125,000 | Aug 8, 2025 |
| May 1, 2025 | Prasad Anjaneya jeereddi CEO | POpen-market purchase Common Stock | +3,000 | $0.75 | $2,250 | 1,531,983 | May 2, 2025 |
| Nov 29, 2024 | William St Lawrence director | AGrant or award Common Stock | +75,000 | - | - | 125,000 | Dec 2, 2024 |
| Nov 29, 2024 | William F. Leimkuhler director | AGrant or award Common Stock | +75,000 | - | - | 225,000 | Dec 2, 2024 |
| Nov 29, 2024 | Prasad Anjaneya jeereddi CEO | AGrant or award Common Stock | +250,000 | - | - | 1,528,983 | Dec 2, 2024 |
| Nov 5, 2024 | Prasad Anjaneya jeereddi CEO | POpen-market purchase Common Stock | +2,000 | $0.75 | $1,500 | 1,278,983 | Nov 6, 2024 |
| Nov 5, 2024 | Prasad Anjaneya jeereddi CEO | POpen-market purchase Common Stock | +1,000 | $1.00 | $1,000 | 1,279,983 | Nov 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Alan Golddirector
- William F. Leimkuhlerdirector
- Kenneth A MinorChief Financial Officer
- William St Lawrencedirector
- Prasad Anjaneya jeereddiCEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.